Isolere Bio, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Isolere Bio, Inc. - overview
Established
2017
Location
Durham, NC, US
Primary Industry
Biotechnology
About
Based in North Carolina, US, and founded in 2017, Isolere Bio, Inc. provides a wide range of solutions related to the manufacturing of complex biologics. The company was founded by Tosh Chilkoti, Joe McMahon, and Kelli Luginbuhl (CEO). In May 2021, the firm raised USD 7 million in Seed funding led by investor Northpond Ventures.
The company offers tailored manufacturing solutions that help in therapeutic development, harmonize commercial scaling, as well as improve global access to life-changing medicines and vaccines. The offering of firm includes IsoTag which includes reagents and products that can be paired with a platform process that uses existing equipment and off-the-shelf consumables. The product range includes IsoTag AAV and IsoTag LV.
Current Investors
Northpond Ventures, North Carolina Biotechnology Center
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.isolerebio.com
Verticals
Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.